MedTrace Logo

Biobanking and New Biomolecular Metrics

NCT05906277 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2023-06-15

No results posted yet for this study

Summary

The goal of this Interventional study aims to apply, in our Institutes, a 4p oncological model i.e. predictive, personalized, of precision and participated (Regina Elena and San Gallicano).

Conditions

  • Melanoma (Skin)
  • Liquid Biopsy

Interventions

DIAGNOSTIC_TEST

Biopsy

Liquid biopsy, re-biopsy, tissue biopsy

Sponsors & Collaborators

  • Istituti Fisioterapici Ospitalieri

    collaborator OTHER

  • Regina Elena Cancer Institute

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SEQUENTIAL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-29
Primary Completion
2022-12-01
Completion
2025-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05906277 on ClinicalTrials.gov